Charansonney, Olivier L.
Morel, Pascal
Dufaux, Jacques
Vicaut, Eric
Article History
Received: 21 April 2022
Accepted: 10 August 2022
First Online: 30 August 2022
Competing interests
: Clinical studies were sponsored by RHEOFAST S.A.S, Evry, France. Devices were provided by RHEOFAST S.A.S.. RHEOFAST was headed by Olivier Charansonney. RHEOFAST has ended its activities. Olivier Charansonney owns two patents limited to the French territories; these patents are related to the stirring technique (FR15 58580 and FR15 58581). Other authors do not have competing interests.